Thulium laser vaporesection of the prostate: Can we operate without interrupting oral antiplatelet/anticoagulant therapy?

Sener T. E., Buttice S., Macchione L., Netsch C., TANIDIR Y., Dragos L., ...Daha Fazla

INVESTIGATIVE AND CLINICAL UROLOGY, cilt.58, sa.3, ss.192-199, 2017 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 58 Sayı: 3
  • Basım Tarihi: 2017
  • Doi Numarası: 10.4111/icu.2017.58.3.192
  • Dergi Adı: INVESTIGATIVE AND CLINICAL UROLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.192-199
  • Marmara Üniversitesi Adresli: Evet

Özet

Purpose: Thulium vaporesection of the prostate (ThuVARP) is a new and safe approach for patients receiving anticoagulant therapy in whom transurethral resection of the prostate (TURP) may possess a high bleeding risk. We aimed to demonstrate the efficacy and safety of ThuVARP in patients receiving oral antiplatelet/anticoagulant (OAP/OAC) therapy.